T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding T2 Biosystems, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 34 | 32 | −2 |
| Shares | 3.37M | 6.42M | +3.05M (+90.4%) |
| Value | $1.55M | $451.5K | −$1.10M (−70.9%) |
New holders (7)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 953,656 | $67.0K | 0.00% |
| IHT Wealth Management, LLC | 200,900 | $14.2K | 0.00% |
| Cubist Systematic Strategies, LLC | 168,137 | $11.9K | 0.00% |
| Jane Street Group, LLC | 78,550 | $5.55K | 0.00% |
| Baader Bank INC | 77,673 | $4.26K | 0.00% |
| RFP Financial Group LLC | 40 | $3 | 0.00% |
| Simplex Trading, LLC | 4,275 | $0 | 0.00% |
Sold out (9)
Institutions that held T2 Biosystems, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Hudson Bay Capital Management LP | 651,300 | $299.6K |
| CVI Holdings, LLC | 549,542 | $252.8K |
| Anson Funds Management LP | 525,038 | $241.5K |
| Walleye Capital LLC | 390,978 | $179.8K |
| Vanguard Group Inc | 132,304 | $60.9K |
| Bank of New York Mellon Corp | 60,313 | $27.7K |
| Capital Advisors, Ltd. LLC | 1,439 | $1.00K |
| National Bank of Canada | 40 | $18 |
| Advisory Services Network, LLC | 40 | $18 |